The Competition Bureau of Canada is investigating whether a method of prolonging drug
patents contravenes Canadian law. The investigation began after a coalition of union and …

The Competition Bureau of Canada is investigating whether a method of prolonging drug
patents contravenes Canadian law. The investigation began after a coalition of union and …

It has become almost axiomatic in the pharmaceutical world that litigation has replaced
innovation as the primary mode of operation, says the head of the Canadian Generic …

Then again, perhaps complaints about too many costly court battles have little merit,
considering litigation may be at the very heart of the generic industry's business model …

There is a widespread perception that drug prices in the US are much higher than they
should be, and that the problem is only getting worse. Critics argue that the pharmaceutical …

US pharmaceutical patent policy is poised for a major review by the US Supreme Court.
Later this month, the Court will hear a case, Federal Trade Commission (FTC) v. Actavis …

A recent Senate committee hearing on Bill S-17, Parliament's effort to comply with
international trade rules by extending pharmaceutical patent protection to 20 years …

Drug Administration (FDA) is" to pro-mote and protect the public health by helping safe and
effective products reach the market in a timely way." Unfortunately, that mission has been …

The smile the chairman flashed at the speaker was dangerously benevo-lent.“I would like to
welcome you to these public policy hearings,” he said.“We look forward to listening to your …

Round one was an epic political struggle between the international brand-name drug
companies-the research-based side of the industry-and the upstart domestic producers of …